Impact of Lipoabdominoplasty and Rectus Diastasis Repair on Benzodiazepine Usage in Patients with Depression and Anxiety: A Prospective Study

Background: Lipoabdominoplasty, primarily sought for cosmetic enhancement, has shown potential benefits beyond physical transformation. Emerging evidence suggests aesthetic procedures may positively impact mental health by improving body image and self-esteem. This study aims to assess the impact of lipoabdominoplasty on pharmacological therapy (BDZ) in patients with pre-existing depression or anxiety disorders. Methods: This prospective cohort study included 69 patients who underwent lipoabdominoplasty. All patients were on BDZ prior to surgery, with dosage frequency recorded. Follow-up assessments were conducted postoperatively to document changes in drugs use and evaluate mental health improvements using validated scales, including the BodyQ. Results: Postoperatively, a significant reduction in drug use was observed. At follow-up, 17% of patients discontinued medication, while 61% required a lower dosage (p<0.05). Complications occurred in 16% of cases, including seroma (n=6), infection (n=2), hematoma (n=2), and necrosis (n=1); one patient required reintervention. BodyQ scores demonstrated significant improvements in body image and self-esteem. Conclusions: Lipoabdominoplasty may contribute to reduced drugs use, likely driven by improvements in body image and psychological well-being. These findings underscore the potential of aesthetic surgery to enhance mental health in patients with depression or anxiety, offering a integrated holistic care approach.